← Fundnode · Learn

State hub · Maryland healthcare

Healthcare MCA in Maryland — funders, SBA vs MCA math, practice profiles.

Maryland healthcare runs on a concentration of academic and federal medical institutions that no other state can match. Johns Hopkins Hospital and the University of Maryland Medical Center anchor Baltimore as one of the densest specialty referral cities per capita in the world. Bethesda hosts the NIH Clinical Center and Walter Reed National Military Medical Center — two of the most prestigious federal medical institutions in the country, employing thousands of physicians and creating a downstream specialty referral ecosystem unique to the DC suburbs. MD HB 1071, the Maryland Commercial Financing Disclosure Law, took effect January 2025 and is among the strictest disclosure regimes in the country. Here is the honest map.

By Keerthana Keti10 min read

Maryland healthcare market context

Maryland HB 1071, the Maryland Commercial Financing Disclosure Law, took effect January 2025. HB 1071 requires non-bank commercial financing providers to disclose APR-equivalent, total cost of capital, payment amount and frequency, prepayment charges, and standardized fee disclosures on offers of $500K or less to MD businesses. The MD disclosure structure is similar to VA SB 1252 and OH SB 232 and covers the vast majority of MD healthcare practice MCA deals. Several opaque-pricing MCA funders pulled back from MD originations in late 2024 (in advance of the January 2025 effective date) and through 2025; the funders that remain provide cleaner offer letters. The Maryland Board of Physicians and Maryland State Board of Dental Examiners maintain practitioner-ownership rules with moderate flexibility. MD has seen meaningful DSO and PE-backed dental specialty rollups in Montgomery County and Howard County over the last 5 years, though less aggressively than NJ or FL. The downstream effect on funding: practice acquisition financing (SBA 7(a) and specialty medical term loans) is active, with regular exit liquidity for owners. Federal medical hiring at NIH, Walter Reed, Food and Drug Administration (FDA), Centers for Medicare and Medicaid Services (CMS), and other federal medical agencies in the Bethesda-Rockville corridor creates a uniquely strong commercial insurance patient demographic. Federal Employees Health Benefits (FEHB) plans are among the most reliable commercial payers in the country, with predictable reimbursement schedules and short AR cycles (typically 30-40 days). Bethesda-area specialty practices serving FEHB-heavy patient populations enjoy unusually clean cash flow profiles. Johns Hopkins Hospital is the largest non-government employer in Maryland and operates one of the largest integrated academic specialty referral networks in the world. Independent specialty practices in surrounding Baltimore neighborhoods benefit from Hopkins overflow referrals; these practices typically have strong commercial-payer mix and high goodwill valuations — they are among the most attractive SBA and specialty medical lender credits in the Mid-Atlantic. Maryland is unique in having an all-payer hospital rate-setting system (administered by the Health Services Cost Review Commission, HSCRC) that sets uniform hospital reimbursement rates across all payers (commercial, Medicare, Medicaid). This affects hospital pricing but does not directly affect independent physician practice reimbursement — physician fee schedules remain governed by individual payer contracts. The HSCRC system does, however, indirectly affect practice economics by limiting hospital pricing leverage in physician-hospital alignment negotiations. MD Medicaid managed care (HealthChoice) reimburses through eight MCO plans with payment cycles of 45-75 days. Per-visit rates are mid-to-upper-pack nationally, particularly for primary care. Maryland's 2014 Medicaid expansion produced meaningful coverage growth. Practice sizes we see most often: solo practitioners ($50K-$200K, often SBA Express), Bethesda and Baltimore group practices ($200K-$1M via SBA 7(a)), Bethesda and Howard County multi-location specialty and DSO consolidations ($1M-$5M via Live Oak, BHG, or specialty medical lenders).

Top funders for Maryland healthcare practices

Live Oak Bank

Strong MD healthcare SBA 7(a) volume across Baltimore, Bethesda, and Howard County. Particularly active on Bethesda dental specialty and dermatology acquisitions serving the NIH and Walter Reed federal medical employee base, plus Baltimore Hopkins-adjacent specialty practice expansions. Specialty underwriting depth wins on FEHB-heavy practice transactions.

Bankers Healthcare Group

Specialty medical bank term loans up to $500K. Strong MD volume among established independent practices in Bethesda and Howard County wanting faster underwriting than SBA, particularly federal-employer-adjacent specialty groups.

Credibly

MD HB 1071 compliant; multi-product flexibility (MCA, term, LOC); transparent factor-rate disclosure post-HB 1071. Active Baltimore and Montgomery County originations; fits when SBA timing genuinely cannot work.

Bluevine

HB 1071 compliant LOC for established MD practices with 12+ months and 625+ credit. APR 14-22% materially beats MCA cost for working capital needs; the LOC stays available after initial draw.

Maryland cities and healthcare markets

  • Baltimore — Johns Hopkins Hospital and University of Maryland Medical Center anchor one of the densest specialty referral cities per capita in the world. MedStar Union Memorial, Mercy Medical, and LifeBridge Sinai provide secondary referral capacity. Independent specialty practices in Mount Vernon, Federal Hill, Hampden, and Hopkins-adjacent neighborhoods benefit from academic overflow referrals; deal sizes $200K-$1M typical. Mixed commercial/Medicaid payer mix.
  • Bethesda / Chevy Chase (Montgomery County) — NIH Clinical Center, Walter Reed National Military Medical Center, and Suburban Hospital (Johns Hopkins affiliate) anchor specialty referrals across MD's wealthiest patient demographic. Independent specialty practices serving NIH and federal medical employees enjoy premium commercial insurance (FEHB) reimbursement and unusually short AR cycles (30-40 days). Cash-pay aesthetics and concierge medicine concentrate here. Deal sizes skew large ($300K-$1.5M); exceptional SBA profile.
  • Silver Spring / Rockville (Montgomery County) — MedStar Montgomery and Holy Cross Hospital anchor regional referrals. Diverse population with strong commercial insurance mix from federal contractor and biotech employer base. Growing dental specialty and pediatric medicine concentration. Deal sizes $150K-$600K typical.
  • Columbia / Howard County — Howard County General Hospital (Johns Hopkins affiliate) anchors regional referrals. One of the wealthiest counties per capita in the US, with strong commercial insurance and high cash-pay capacity. Independent dental specialty, dermatology, and primary care practices serve a stable professional patient base. Deal sizes $150K-$600K typical.
  • Annapolis / Anne Arundel County — Anne Arundel Medical Center anchors regional referrals. Naval Academy and Coast Guard medical populations create meaningful TRICARE patient base. Mid-size practice density with mixed commercial/TRICARE/Medicare payer mix. Premium specialty practices serving boating and retiree communities are a niche segment.

The funding math, in Maryland terms

A 3-physician dermatology practice in Bethesda doing $480K/month in revenue (65% commercial including 35% FEHB / 20% cash-pay aesthetics and cosmetic dermatology / 10% Medicare / 5% HealthChoice Medicaid) needs $400K to add a Mohs surgery suite (procedure room buildout, surgical equipment, fellowship-trained Mohs surgeon recruitment package). - Live Oak Bank SBA 7(a) over 10 years: $400K at prime + 2.5-3% (~10.5-11% in mid-2026), monthly payment ~$5,400. SBA 7(a) is purpose-built for procedure-suite plus personnel expansion; Mohs surgery materially improves practice margin profile (captures complex procedure revenue currently referred out), which strengthens SBA debt service coverage analysis. Bethesda FEHB-heavy commercial mix produces clean cash flow profile that Live Oak underwrites confidently. Closes in 35-45 days. - Bankers Healthcare Group practice term loan: $400K over 7 years at ~13-15% fixed, monthly payment ~$7,500. Closes in 2-3 weeks; no UCC blanket lien on practice assets. Fits if practice wants speed plus structural flexibility for the Mohs surgeon recruitment timeline. - Bluevine LOC: $250K cap (max), would cover only part of the need. APR 14-22%; useful for any working capital portion of the buildout and Mohs surgeon ramp. - $400K MCA at 1.26 factor over 12 months: $504K payback, ~$1,400/day ACH. With required MD HB 1071 disclosure, APR-equivalent prints around 50-60% on the offer letter. Daily payment would consume roughly 9% of average daily revenue during the Mohs surgeon ramp period when his/her panel is still building. Best fit: Live Oak SBA 7(a) for cheapest cost of capital and right structure for procedure-suite plus personnel expansion. BHG if the 2-3 week timing advantage matters or the Mohs surgeon recruitment timeline demands faster close. MCA is the wrong tool for this Bethesda dermatology expansion — HB 1071 disclosure makes the cost gap impossible to ignore, and the Mohs panel-build timeline misaligns with MCA daily payback structure.

Related reading for Maryland healthcare practitioners

Frequently asked questions

Frequently asked questions

What does MD HB 1071 actually require on a healthcare MCA offer letter?
Any MCA or commercial financing provider offering an MD business $500K or less (since January 2025) must disclose: total amount financed, total payback amount, APR-equivalent, payment amount and frequency, prepayment charges, and total cost of capital expressed as a dollar amount. The disclosure threshold ($500K) covers the vast majority of MD healthcare practice MCA deals. Brokers placing the deal share the disclosure obligation. If you receive an MD MCA offer without these disclosures, the funder is likely not HB 1071 compliant — push back or shop elsewhere.
How does federal medical hiring (NIH, Walter Reed, FDA, CMS) affect Bethesda specialty practice funding?
The Bethesda-Rockville corridor hosts thousands of physicians, scientists, and administrators employed by NIH, Walter Reed National Military Medical Center, FDA, CMS, and related federal medical agencies. These federal employees use Federal Employees Health Benefits (FEHB) plans — among the most reliable commercial payers in the country, with predictable reimbursement schedules and short AR cycles (30-40 days). Bethesda specialty practices with FEHB-heavy patient mix enjoy unusually clean cash flow profiles, which strengthens SBA debt service coverage analysis. Live Oak and BHG both actively favor Bethesda FEHB-heavy practices for acquisition and expansion financing.
How does Johns Hopkins Hospital affect independent practice funding in Baltimore?
Johns Hopkins Hospital is the largest non-government employer in Maryland and operates one of the largest integrated academic specialty referral networks in the world. Independent specialty practices in surrounding Baltimore neighborhoods (Mount Vernon, Federal Hill, Hampden, Hopkins-adjacent areas) benefit from Hopkins overflow referrals, which produces strong commercial-payer mix, short AR cycles, and high goodwill valuations. These independent practices are among the most attractive SBA and specialty medical lender credits in the Mid-Atlantic. Johns Hopkins also employs many physicians directly, but does not crowd out independent specialty practices the way some academic systems do — the patient volume is simply too large for the academic system alone to absorb.
Does the MD HSCRC all-payer hospital rate-setting system affect physician practice funding?
Not directly. The HSCRC system sets uniform hospital reimbursement rates across all payers (commercial, Medicare, Medicaid), which affects hospital pricing but does not govern independent physician practice fee schedules — those remain set by individual payer contracts. The indirect effect on physician practices: HSCRC limits hospital pricing leverage in physician-hospital alignment negotiations, which has historically slowed health-system acquisition of independent practices in MD relative to states without rate-setting. The downstream effect on funding: more independent practices remain SBA-eligible in MD than in states with aggressive health-system practice consolidation.
What is a typical MD specialty practice MCA rate post-HB 1071?
B-paper (12+ months, $40K+/mo, 600+ credit): 1.22-1.34 at direct funders post-HB 1071 (slightly tighter than pre-disclosure because opaque operators exited). A-paper (24+ months, $75K+/mo, 650+ credit): 1.18-1.28 reachable. Bethesda FEHB-heavy practices often reach the tightest end of the A-paper range due to clean cash flow profiles. Always shop direct first — HB 1071 makes funder-direct pricing comparison straightforward and broker markup more visible than in pre-disclosure markets.